Stroke Survivors More Likely to Have Abnormal Sleep Duration
By Elana Gotkine HealthDay Reporter
THURSDAY, Sept. 12, 2024 -- U.S. stroke survivors are more likely to have abnormal sleep duration when compared with individuals who have not had a stroke, according to a study published online Sept. 11 in Neurology.
Sara Hassani, M.D., from Duke University School of Medicine in Durham, North Carolina, and colleagues used data from the National Health and Nutrition Examination Surveys database for 2005 to 2018 to compare sleep duration among individuals with and without prior stroke. A total of 37,987 without self-reported stroke and 1,572 with self-reported stroke were included.
The researchers found that individuals with prior stroke were more likely to report more than eight hours/night (unadjusted odds ratio [OR], 2.03; 95 percent confidence interval [CI], 1.64 to 2.51), less than seven hours/night (OR, 1.29; 95 percent CI, 1.08 to 1.53), and less than six hours/night (OR, 1.87; 95 percent CI, 1.53 to 2.29) compared with individuals without stroke. These associations were attenuated after adjustment.
"Future research should explore the causal links between stroke by type and duration of sleep and determine the effect of sleep duration on outcomes after stroke," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
CPAP Preferentially Improves Cardiovascular Outcomes in High-Risk OSA
WEDNESDAY, Aug. 6, 2025 -- In patients with high-risk obstructive sleep apnea (OSA), continuous positive airway pressure (CPAP) improves cardiovascular outcomes, while harm may be...
Risk of Long COVID Greater for Individuals With Social Risk Factors
THURSDAY, July 31, 2025 -- Individuals with social risk factors at the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have increased risk for...
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.